[gpt3]Rewrite this news into an original 800+ word blog post for a global audience, as if you’re an experienced journalist on the ground. Use your own words and perspective—don’t just paraphrase. Make it human, warm, textured, and creative, with the voice of a real AP reporter.
Vary sentence lengths, keep it SEO-friendly, and add authentic quotes, data, cultural references, and anecdotes. Connect events to wider trends and ask readers thought-provoking questions.
Format for WordPress:
for main sections
for subsections
for paragraphs
- for bullets
- for numbered lists only when order matters
End with this exact signature:
By Ali Musa
Axadle Times international–Monitoring.The Africa Centres for Disease Control and Prevention (Africa CDC) has welcomed the approval of the first malaria treatment designed for newborns and infants under five kilograms, calling it a “major step forward”.
The new artemether-lumefantrin formulation for children was developed through a partnership between Novartis and the Medicines for Malaria Venture (MMV), under the PAMAfrica consortium, and 8 African countries participated in clinical trials: Burkina Faso, Côte d’Ivoire, Kenya, Malawi, Mozambique, Nigeria, Tanzania, and Uganda.
Children under 5 were often given modified doses of medicines for older children, raising the risk of overdose and toxicity. This new formulation offers a safe, effective, and infant-friendly option, dissolvable in breast milk and with a sweet flavour to ease administration.
- for numbered lists only when order matters
